Double-blind, Placebo-controlled Trial of Antithrombin III Concentrates in Septic Shock With Disseminated Intravascular Coagulation

This publication has 20 references indexed in Scilit:

• The Orchestra of Mediators in the Pathogenesis of Septic Shock: A Review
  Published by Springer Nature ,1991
• Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates
  Intensive Care Medicine, 1990
• Acquired antithrombin III deficiency: Laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate
  The American Journal of Medicine, 1989
• Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia
  The American Journal of Medicine, 1989
• The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution*
  European Journal of Haematology, 1989
• Heparin Promotes the Inactivation of Antithrombin by Neutrophil Elastase
  Science, 1987
• Clinical Evaluation of Antithrombin III Concentrate (BI 6.013) for Disseminated Intravascular Coagulation in Obstetrics
  Gynecologic and Obstetric Investigation, 1987
• Antithrombin, Prekallikrein, and Fibronectin Levels in Surgical Patients
  Published by American Medical Association (AMA) ,1986
• Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients
  Intensive Care Medicine, 1984
• Substitution therapy with an antithrombin III concentrate in shock and DIC
  Thrombosis Research, 1982